contraception – Commercialisation des dispositifs médicaux contraceptifs sans essai clinique

This written question asks about the commercialisation of contraceptive medical devices without requiring clinical trials. It seeks clarification on the regulatory framework and safety assurances for such products. The question concerns the potential impact on public health and consumer safety. It highlights the need for robust oversight of medical devices, particularly those related to reproductive health.